ClinicalTrials.Veeva

Menu

Integrated Recovery Program for Critical Illness (iCARE)

National Taiwan University logo

National Taiwan University

Status

Enrolling

Conditions

ICU Survivors

Treatments

Behavioral: LINE Bot-Based Remote Care Combined with In-Person Post-ICU Clinic

Study type

Interventional

Funder types

Other

Identifiers

NCT06997822
202502049RINA

Details and patient eligibility

About

This study aims to investigate the effects of the Integrated Critical Illness Aftercare and Recovery Enhancement (I-CARE) program on reducing healthcare burden and improving functional outcomes in ICU survivors. The I-CARE program combines remote support via LINE Bot Care with in-person post-ICU recovery clinic visits. The study will assess whether this integrated care model reduces unplanned hospital readmissions and emergency department visits within six months after discharge, and improves physical and cognitive outcomes at 3 and 6 months post-discharge. Additionally, the study will evaluate the impact of a built-in patient-nurse interaction feature on ICU nurses' burnout and intention to leave, measured every six months over a two-year period.

Full description

This randomized clinical trial is designed to evaluate the effectiveness of the Integrated Critical Illness Aftercare and Recovery Enhancement (I-CARE) program for survivors of critical illness discharged from the intensive care unit (ICU). The I-CARE program integrates a LINE Bot-based remote monitoring and support system with structured, in-person post-ICU recovery clinic visits. The primary objective is to determine whether this comprehensive care model can reduce the incidence of unplanned hospital readmissions and emergency department visits within six months after hospital discharge.

Secondary outcomes focus on functional recovery and include assessments of physical mobility (e.g., ability to transition from sit to stand), inspiratory muscle strength, body weight changes, presence of dysphagia, and cognitive function at 3 and 6 months post-discharge.

In addition, the LINE Bot Care system incorporates an interactive feature titled "Thanks to Nurses," which enables ICU survivors to share personal reflections, such as short messages, photos, diary entries, stickers, and audio clips, with their ICU care team. This bidirectional communication channel is intended to enhance emotional support and foster a sense of connection between patients and healthcare providers. The study will evaluate the impact of this feature on ICU nurses' professional well-being, specifically measuring levels of burnout and intention to leave the profession at 6, 12, 18, and 24 months after implementation, using a pre-post intervention design.

Enrollment

240 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ICU survivors who had experienced endotracheal intubation and mechanical ventilation treatment.

Exclusion criteria

  • ICU survivors who are unable to walk independently before admission
  • ICU survivors who are unable to receive assessment (e.g., dementia or mental retardation)
  • ICU survivors who don't have a smartphone.
  • ICU survivors were discharged to institutional care facilities

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

240 participants in 2 patient groups

LINE Bot-Based Remote Care Combined with In-Person Post-ICU Clinic
Experimental group
Description:
LINE Bot-Based Remote Care includes instructional videos for basic mobility skills, recommended exercise practices, cognitive training, and nutritional education. In addition, survivors can report their signs and symptoms to request relevant educational content. At 3 months, participants will attend a post-ICU clinic for comprehensive assessment, necessary interventions, and care transition planning.
Treatment:
Behavioral: LINE Bot-Based Remote Care Combined with In-Person Post-ICU Clinic
Non-Interactive LINE Bot + Assessment-Only Clinic
No Intervention group
Description:
Participants in the control group will be invited to join an official LINE chat, which will not provide any interventions or educational content. They will, however, receive a post-ICU assessment clinic visit at the 3-month follow-up.

Trial contacts and locations

1

Loading...

Central trial contact

Kuo-Jen Hsu, PhD; Cheryl Chia-Hui Chen, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems